2025-2026 FEDERAL LegislatiON
119th Congress (2025-2026)
1. SUPPORTED THE LIFE AT CONCEPTION ACT:
The Dobbs v. Jackson Women's Health Organization U.S. Supreme Court ruling in June 2022 remanded the abortion issue back to the state legislatures and the U.S. Congress to be democratically addressed by the people’s representatives. Accordingly, the 119th U.S. Congress reintroduced legislation that protects the preborn child as a legal person. Offering a national solution to the atrocity of abortion, the legislation applies 14th Amendment protections to all human beings from conception.
On January 24, 2025, U.S. Representative Eric Burlison (R-MO) introduced House Resolution (H.R.) 722, the Life at Conception Act, to implement equal protection under the 14th Amendment to the United States Constitution for the right to life of each born and preborn human person.
The Life at Conception Act is one of the most comprehensive pro-life bills ever introduced by Congress. Through H.R. 722, Congress would establish personhood from the moment of conception to extend the equal protection and due process rights of our federal constitution to all human beings from the beginning of their lives.
H.R. 722 has so far been co-sponsored by 105 representatives, including U.S. Rep. Scott Fitzgerald (R-WI-05), and has been referred to the House Committee on the Judiciary.
2. SUPPORTED THE SAFEGUARDING WOMEN FROM CHEMICAL ABORTION ACT:
On March 11, 2026, U.S. Senator Josh Hawley (R-MO) introduced Senate Bill (S.) 4066, the Safeguarding Women from Chemical Abortion Act, which would 1) remove the federal Food and Drug Administration’s (FDA) approval of mifepristone for abortion, and 2) create a private right of action for women harmed by mifepristone to sue its corporate manufacturers for damages.
S.4066 would end the extreme physical and emotional dangers of do-it-yourself, at-home abortions. It would effectively stop the flood of mail-order shipments of mifepristone into pro-life states. In August of 2025, the Ethics and Public Policy Center (EPPC), using insurance claims data in the largest-known study of the abortion pill, found that 10.93 percent of women – roughly 1 in10 - experience sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion. This rate is at least 22 times higher than the adverse-event rate reported on the drug manufacturer’s label.
According to Hawley, “The evidence is now clear. Mifepristone is almost always fatal to the unborn child, but it is also significantly dangerous for women. The drug companies that make this drug know this but continue to profit from the drug’s nearly unregulated distribution, largely insulated from liability. Congress can no longer ignore these dangers.”
S.4066 has so far been co-sponsored by four senators and has been referred to the Senate Committee on Health, Education, Labor, and Pensions.
3. SUPPORTED THE FACE ACT REPEAL ACT:
On January 21, 2025, U.S. Representative Chip Roy (R-TX-21) introduced House Resolution (H.R.) 589, the FACE Act Repeal Act of 2025, to repeal prohibitions relating to the Freedom of Access to Clinic Entrances (FACE) law, or, according to Rep. Roy, “to permanently end a law that has too long been weaponized against pro-life Americans.” According to Roy, “The FACE Act was one of the primary weapons of abuse - being used to politically target, arrest, and jail pro-life Americans for speaking out and standing up for life.”
H.R. 589 has so far been co-sponsored by 42 representatives, including U.S. Rep. Glenn Grothman (R-WI-06), and has been referred to the House Committee on the Judiciary.
4. SUPPORTED THE PROTECTING LIFE AND INTEGRITY IN RESEARCH ACT:
On March 11, 2025, H.R. 2075 U.S. Representative Robert Onder (R-MO-3) introduced House Resolution (H.R.) 2075, the Protecting Life and Integrity in Research Act of 2025, to prohibit the federal government from conducting, funding, approving, or supporting any research involving human fetal tissue that is obtained from an induced abortion and prohibits the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue. H.R. 2027 does NOT make any restrictions on tissue collected from miscarriages and stillbirths.
According to Rep. Onder, ““The creation of a taxpayer-funded marketplace for babies lost to abortion is a monstrous, barbaric practice. Every baby, including those lost to abortion, deserves to be treated with human decency and respect - not like raw material for science experiments.”
H.R. 2075 has so far been co-sponsored by 33 representatives, including U.S. Rep. Glenn Grothman (R-WI-06), and has been referred to the House Committee on Energy and Commerce.
5. OPPOSED THE WOMEN’S HEALTH PROTECTION ACT:
On June 24, 2025, U.S. Representative Judy Chu (D-CA-28) introduced House Resolution (H.R.) 12, the Women’s Health Protection Act of 2025, which effectively codifies a national right to abortion by outlawing virtually all state abortion restrictions, including informed consent /waiting period laws, requiring abortion clinics to meet the same standards as surgical centers, requiring abortion providers have admitting privileges at a nearby hospital, and banning telemedicine chemical abortions.
H.R. 12 has so far been co-sponsored by 207 representatives, including U.S. Rep. Gwen Moore (D-WI-04) and U.S. Rep. Mark Pocan (D-WI-02), and has been referred to the House Committee on Energy and Commerce.